Saatvik Green Secures ₹87.10 Crore Solar Module Order

Saatvik Green Energy Limited has strengthened its order book with a new commercial contract valued at ₹87.10 crore. The company will supply solar photovoltaic modules to a reputed Independent Power Producer and EPC player within India.
Domestic Order Boosts Solar Portfolio
The contract involves the supply of solar PV modules for a domestic project. The company has confirmed that the full order has been accepted and will be executed by March 2026.
This fresh mandate adds to Saatvik Green’s growing presence in India’s renewable energy ecosystem, particularly in utility-scale solar deployments.
Strengthening Market Position
With demand for solar installations continuing to expand across the country, the new ₹87.10 crore order enhances the company’s visibility in the commercial solar supply segment.
By delivering within the committed timeline, Saatvik Green aims to further consolidate its standing among Independent Power Producers and EPC partners in the domestic market.
Read More: Vikram Solar Share Price in Focus; Secures 378.75 MW Order from INGEL for High Efficiency Modules!
Saatvik Green Energy Share Price Performance
As of 26 February 2026, at AM, Saatvik Green Energy Ltd share price is trading at ₹384.55 per share, reflecting a surge of 0.94% from the previous closing price. Over the past month, the stock has surged by 5.78%.
Conclusion
The latest contract underscores Saatvik Green Energy’s ongoing traction in the renewable sector. As project execution progresses toward March 2026, the ₹87.10 crore order is expected to contribute meaningfully to its near-term revenue pipeline.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 26, 2026, 11:11 AM IST

Team Angel One
- Alembic Pharmaceuticals Share Price in Focus; US FDA Issues Form 483 With No Observations for Bioequivalence Unit in Gujarat
- Adani Ports Share Price in Focus; Receives SEBI Settlement Order Concerning Former Executives
- Glenmark Pharmaceuticals Share Price in Focus; Launches RYALTRIS Nasal Spray in Brazil
- Premier Energies Share Price in Focus; Unit Enters Binding Term Sheet for JV with RCT Energy India
- Mphasis Share Price in Focus; Partners with SGBS Unnati Foundation for Greener Bengaluru


